Survey

With the recent announcement of Medco's acquisition by Express Scripts, potentially bringing 2 of the nation's largest PBMs together, what do you see as the most significant implications of such consolidation for the industry?

a) Enhanced competition within the industry, inevitably translating to even lower drug costs for PBM payer clients.

b) Unfair advantages for Express Scripts based upon its size, thus reducing competition and potentially increasing long-term costs for payers.

c) Increased pressures on retail pharmacies forcing more pharmacies out of business.

d) Increased quality of PBM clinical, analytic and administrative services across the industry, as other PBMs strive to stay competitive.

e) Minimal, if any, impact.

Digital Edition

First-ever CAP guidelines for infants and children

To confirm your e-newsletter subscription, click here.

To ensure future delivery of email newsletters from Formulary, please take a moment to confirm your subscription by clicking here.
Thank you,
Formulary Staff

FDA approves 2 new indications for denosumab

Lixisenatide 1-step as effective as 2-step regimen in improving glycemic control in type 2 diabetes

Lixisenatide (Lyxumia, Sanofi), a once-daily GLP-1 receptor agonist under development for type 2 diabetes, achieved its primary efficacy end point of significant HbA_1c reduction versus placebo in patients uncontrolled on metformin. Read full article.

FDA oncology office realigns by expertise, disease areas

FDA announced that the Center for Drug Evaluation and Research's Office of Oncology Drug Products will now be called the Office of Hematology and Oncology Products. Read full article.

NSAIDs increase miscarriage risk in early pregnancy

Nonsteroidal anti-inflammatory drugs (NSAIDs) should be used with caution during pregnancy, as exposure may increase the risk of spontaneous abortion, reported a study published online September 6 in the Canadian Medical Association Journal. Read full article.

Warfarin patients should be monitored for acetaminophen interactions

An interaction between warfarin and acetaminophen may result in significant elevations of international normalized ratio, putting patients at increased risk for hemorrhagic complications, reported a literature review published in the June issue of Pharmacotherapy. Read full article.